Literature DB >> 24112666

Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.

Khaled M Madbouly1, Khaled S Abbas2, Ahmed M Hussein2.   

Abstract

BACKGROUND: The aim of this study was to assess the prognostic value of metastatic lymph node (LN) ratio (MLNR) in stage III rectal cancer and whether this prognostic value remains significant when <12 LNs are retrieved.
METHODS: This prospective study included 115 patients with stage III rectal cancer from 2006 to 2010. All patients underwent neoadjuvant long-course chemoradiation, curative resection, and postoperative adjuvant therapy (5-fluorouracil and leucovorin). Data collected included demographics, tumor pathology, tumor-node-metastasis staging, number of LNs retrieved, MLNR, recurrence, and mortality.
RESULTS: The mean number of examined LNs was 12.1, and the mean number of metastatic LNs was 3.5 (range, 1 to 19). The mean MLNR was .37 (range, 0 to 1.00). The mean duration of follow-up was 37 months (range, 24 to 63). Forty patients died during the follow-up period (overall mortality, 34.8%), only 31 because of cancer (cancer-specific mortality, 27%). Univariate analysis revealed that ypN stage, lymphovascular invasion, and follow-up duration were significantly associated with increased recurrence and decreased survival. Number of positive nodes and ypT stage significantly affected recurrence, with no effect on overall survival. Multivariate analysis proved that MLNR was the only independent risk factor for both mortality and recurrence. Prognostic capability was not affected by having <12 nodes retrieved. The best sensitivity and specificity of MLNR as a prognostic factor for both tumor recurrence and overall survival were achieved at a cutoff value of .375.
CONCLUSIONS: MLNR is an independent prognostic factor for recurrence and survival after the resection of stage III rectal cancer, with high sensitivity and specificity in patients who received neoadjuvant chemoradiation and postoperative chemotherapy. The total number of LN retrieved did not affect the prognostic value of MLNR even if <12.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Metastatic lymph node ratio; Rectal cancer; Recurrence

Mesh:

Substances:

Year:  2013        PMID: 24112666     DOI: 10.1016/j.amjsurg.2013.07.022

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  13 in total

1.  Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examined.

Authors:  Kewei Jiang; Yi Zhu; Yan Liu; Yingjiang Ye; Qiwei Xie; Xiaodong Yang; Shan Wang
Journal:  Tumour Biol       Date:  2014-08-21

2.  Whole-tumour diffusion kurtosis MR imaging histogram analysis of rectal adenocarcinoma: Correlation with clinical pathologic prognostic factors.

Authors:  Yanfen Cui; Xiaotang Yang; Xiaosong Du; Zhizheng Zhuo; Lei Xin; Xintao Cheng
Journal:  Eur Radiol       Date:  2017-10-23       Impact factor: 5.315

3.  Accuracy of MRI for nodal restaging in rectal cancer: a retrospective study of 166 cases.

Authors:  Sayali Pangarkar; Kunal Mistry; Amit Choudhari; Vasundhara Smriti; Ankita Ahuja; Aparna Katdare; Reena Engineer; Vikas Ostwal; Mukta Ramadwar; Avanish Saklani; Akshay D Baheti
Journal:  Abdom Radiol (NY)       Date:  2020-08-19

4.  The value of lymph node ratio in the prediction of rectal cancer patient survival after preoperative chemoradiotherapy.

Authors:  Li Chen; Xuefeng Huang; Zhangfa Song
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

Review 5.  Pathologic processing of the total mesorectal excision.

Authors:  Molly Campa-Thompson; Robert Weir; Natalie Calcetera; Philip Quirke; Susanne Carmack
Journal:  Clin Colon Rectal Surg       Date:  2015-03

6.  The role of lymph nodes in predicting the prognosis of ampullary carcinoma after curative resection.

Authors:  Shih-Chin Chen; Yi-Ming Shyr; Shu-Cheng Chou; Shin-E Wang
Journal:  World J Surg Oncol       Date:  2015-07-25       Impact factor: 2.754

7.  Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy.

Authors:  Taeryool Koo; Changhoon Song; Jae-Sung Kim; Kyubo Kim; Eui Kyu Chie; Sung-Bum Kang; Keun-Wook Lee; Jee Hyun Kim; Seung-Yong Jeong; Tae-You Kim
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

8.  Robotic-assisted surgery versus open surgery in the treatment of rectal cancer: the current evidence.

Authors:  Guixiang Liao; Yan-Bing Li; Zhihong Zhao; Xianming Li; Haijun Deng; Gang Li
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

9.  The number of metastatic lymph nodes exhibiting poorly differentiated clusters predicts survival in patients with pStage III colorectal cancer.

Authors:  Osamu Kinoshita; Mitsuo Kishimoto; Yasutoshi Murayama; Yoshiaki Kuriu; Masayoshi Nakanishi; Chohei Sakakura; Eigo Otsuji; Akio Yanagisawa
Journal:  Int J Colorectal Dis       Date:  2015-09-28       Impact factor: 2.571

10.  Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.

Authors:  Zhi-Gui Zuo; Xiu-Feng Zhang; Hao Wang; Qi-Zhi Liu; Xing-Zhao Ye; Chang Xu; Xiang-Bin Wu; Jian-Hui Cai; Zhen-Hua Zhou; Jin-Lei Li; Hua-Yu Song; Zu-Qiang Luo; Peng Li; Shi-Chang Ni; Lei Jiang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.